Somatic homozygous deletion, labeled as deep deletion, were observed in BRCA2 in a single breast cancer patient and in pancreatic cancer (RAD51B (n = 2), RAD51C (n = 2) and XRCC2 (n = 1)) (Supplementary Table S1). Here, XRCC2 is linked to familial pancreatic carcinoma.